187 related articles for article (PubMed ID: 31892991)
1. A 6-Membrane Protein Gene score for prognostic prediction of cytogenetically normal acute myeloid leukemia in multiple cohorts.
Lin SY; Miao YR; Hu FF; Hu H; Zhang Q; Li Q; Chen Z; Guo AY
J Cancer; 2020; 11(1):251-259. PubMed ID: 31892991
[No Abstract] [Full Text] [Related]
2. Identification of STAB1 in Multiple Datasets as a Prognostic Factor for Cytogenetically Normal AML: Mechanism and Drug Indications.
Lin SY; Hu FF; Miao YR; Hu H; Lei Q; Zhang Q; Li Q; Wang H; Chen Z; Guo AY
Mol Ther Nucleic Acids; 2019 Dec; 18():476-484. PubMed ID: 31670197
[TBL] [Abstract][Full Text] [Related]
3. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia.
Deng C; Zeng T; Zhu P; Zhao S; Huang Z; Huang W; Zhang W; Huang X; Fu L
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10015-10025. PubMed ID: 37258721
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia.
Cao L; Zhang W; Liu X; Yang P; Wang J; Hu K; Zhang X; Liu W; He X; Jing H; Yuan X
Sci Rep; 2019 Nov; 9(1):16991. PubMed ID: 31740742
[TBL] [Abstract][Full Text] [Related]
5. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Prediction of Cytogenetically Normal Acute Myeloid Leukemia Based on a Gene Expression Model.
Yang L; Zhang H; Yang X; Lu T; Ma S; Cheng H; Yen K; Cheng T
Front Oncol; 2021; 11():659201. PubMed ID: 34123815
[TBL] [Abstract][Full Text] [Related]
7. A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes.
Yin X; Huang H; Huang S; Xu A; Fan F; Luo S; Yan H; Chen L; Sun C; Hu Y
Front Oncol; 2020; 10():566. PubMed ID: 32373535
[No Abstract] [Full Text] [Related]
8. DNA Repair Expression Profiling to Identify High-Risk Cytogenetically Normal Acute Myeloid Leukemia and Define New Therapeutic Targets.
Gabellier L; Bret C; Bossis G; Cartron G; Moreaux J
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33036275
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase binding protein 1 (MAPKBP1) is an unfavorable prognostic biomarker in cytogenetically normal acute myeloid leukemia.
Fu L; Shi J; Hu K; Wang J; Wang W; Ke X
Oncotarget; 2015 Apr; 6(10):8144-54. PubMed ID: 25924238
[TBL] [Abstract][Full Text] [Related]
10. The establishment of a prognostic scoring model based on the new tumor immune microenvironment classification in acute myeloid leukemia.
Zeng T; Cui L; Huang W; Liu Y; Si C; Qian T; Deng C; Fu L
BMC Med; 2021 Aug; 19(1):176. PubMed ID: 34348737
[TBL] [Abstract][Full Text] [Related]
11. Aberrant
Huang S; Huang Z; Chen P; Feng C
Front Oncol; 2020; 10():1648. PubMed ID: 33014825
[No Abstract] [Full Text] [Related]
12. A new prognostic risk model for acute myeloid leukemia patients based on telomere-related genes.
Zhang F; Du H; Hu C; Song Y
Leuk Res; 2023 Dec; 135():107404. PubMed ID: 37844405
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA LOC644135 is a potential prognostic indicator in cytogenetically normal acute myeloid leukemia.
Huang S; Lu B; Zhu M; Liu M; Sun Z; Pan X; Wei M
Expert Rev Hematol; 2022 Jul; 15(7):657-665. PubMed ID: 35713000
[TBL] [Abstract][Full Text] [Related]
14. A novel scoring system for the quantitative prediction of prognosis in acute myeloid leukemia.
Yu Y; Wang H; Yang JJ; Fang S; Wen YN; Jiao YF; Qian K; Le N; Shan RQ; Gao WJ; Hua BL; Li F
Front Oncol; 2023; 13():1144403. PubMed ID: 37064135
[TBL] [Abstract][Full Text] [Related]
15. High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia.
Shi JL; Fu L; Wang WD
Oncotarget; 2015 Mar; 6(7):5299-309. PubMed ID: 25779662
[TBL] [Abstract][Full Text] [Related]
16. Association of a cytarabine chemosensitivity related gene expression signature with survival in cytogenetically normal acute myeloid leukemia.
Yan H; Wen L; Tan D; Xie P; Pang FM; Zhou HH; Zhang W; Liu ZQ; Tang J; Li X; Chen XP
Oncotarget; 2017 Jan; 8(1):1529-1540. PubMed ID: 27903973
[TBL] [Abstract][Full Text] [Related]
17. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients.
Zhu R; Tao H; Lin W; Tang L; Hu Y
Front Oncol; 2020; 10():574939. PubMed ID: 33330048
[TBL] [Abstract][Full Text] [Related]
18. A 3-miRNA signature predicts prognosis of pediatric and adolescent cytogenetically normal acute myeloid leukemia.
Zhu R; Zhao W; Fan F; Tang L; Liu J; Luo T; Deng J; Hu Y
Oncotarget; 2017 Jun; 8(24):38902-38913. PubMed ID: 28473658
[TBL] [Abstract][Full Text] [Related]
19. A 4-microRNA signature for survival prognosis in pediatric and adolescent acute myeloid leukemia.
Zhu R; Lin W; Zhao W; Fan F; Tang L; Hu Y
J Cell Biochem; 2019 Mar; 120(3):3958-3968. PubMed ID: 30242879
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum miR-34a as a potential biomarker in acute myeloid leukemia.
Huang Y; Zou Y; Lin L; Ma X; Chen H
Cancer Biomark; 2018; 22(4):799-805. PubMed ID: 29945348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
